Arrowhead: The Sarepta Partnership Validates RNAi Platform And Reduces Risk
Arrowhead Pharmaceuticals' stock rallied 17% due to significant pipeline developments and strategic partnerships. Learn more ...
USA TODAY Touchdown Wire on MSN1d
Best photos from Raiders hard fought affair at Arrowhead
No matter what the Raiders are going through as a team, no team has given the Chiefs as much to handle in their own house ...
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global ...
Chiefs vs. Raiders: Patrick Mahomes, Travis Kelce make stylish entrance at Arrowhead Stadium
See what Patrick Mahomes, Travis Kelce, and other #Chiefs stars wore to Arrowhead Stadium ahead of Kansas City’s matchup ...
STAT5d
Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases
Sarepta Therapeutics said it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based ...
Gameranx2d
Helldivers 2 Community Manager Leaves Arrowhead
Helldivers 2 has had an incredibly up and down year, and that has now been added to with the departure of another key team ...
BioPharma Dive4d
Sarepta rebuilds drug pipeline with Arrowhead deal
A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 ...
Chiefs survive at Arrowhead on Black Friday after critical Raiders botched snap: Key takeaways
Kansas City became the first team to clinch a spot in the postseason after earning a stunning Week 13 victory.
FierceBiotech5d
Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead
Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...